Iron	B:C0240066
Deficiency	I:C0240066
Is	O
Common	O
During	O
Remission	O
in	O
Children	O
With	O
Inflammatory	O
Bowel	I:C0021390
Disease	I:C0021390
.	O

Iron	O
Deficiency	I:C0240066
Is	O
Common	O
During	O
Remission	B:C0544452
in	O
Children	O
With	O
Inflammatory	O
Bowel	I:C0021390
Disease	I:C0021390
.	O

Iron	O
Deficiency	I:C0240066
Is	O
Common	O
During	O
Remission	O
in	O
Children	O
With	O
Inflammatory	B:C0021390
Bowel	I:C0021390
Disease	I:C0021390
.	O

The	O
aim	O
was	O
to	O
study	B:C2603343
prevalence	O
of	O
iron	O
deficiency	I:C0240066
in	O
children	O
with	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
(	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
)	O
during	O
remission	O
.	O

The	O
aim	O
was	O
to	O
study	O
prevalence	O
of	O
iron	B:C0240066
deficiency	I:C0240066
in	O
children	O
with	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
(	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
)	O
during	O
remission	O
.	O

The	O
aim	O
was	O
to	O
study	O
prevalence	O
of	O
iron	O
deficiency	I:C0240066
in	O
children	O
with	O
inflammatory	B:C0021390
bowel	I:C0021390
disease	I:C0021390
(	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
)	O
during	O
remission	O
.	O

The	O
aim	O
was	O
to	O
study	O
prevalence	O
of	O
iron	O
deficiency	I:C0240066
in	O
children	O
with	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
(	O
inflammatory	B:C0021390
bowel	I:C0021390
disease	I:C0021390
)	O
during	O
remission	O
.	O

The	O
aim	O
was	O
to	O
study	O
prevalence	O
of	O
iron	O
deficiency	I:C0240066
in	O
children	O
with	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
(	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
)	O
during	O
remission	B:C0544452
.	O

In	O
addition	O
,	O
there	O
was	O
an	O
observational	B:C1518527
evaluation	O
of	O
hematological	O
response	O
to	O
oral	O
iron	O
.	O

In	O
addition	O
,	O
there	O
was	O
an	O
observational	O
evaluation	B:C0220825
of	O
hematological	O
response	O
to	O
oral	O
iron	O
.	O

In	O
addition	O
,	O
there	O
was	O
an	O
observational	O
evaluation	O
of	O
hematological	B:C0018941
response	O
to	O
oral	O
iron	O
.	O

In	O
addition	O
,	O
there	O
was	O
an	O
observational	O
evaluation	O
of	O
hematological	O
response	O
to	O
oral	O
iron	B:C0302583
.	O

A	O
population	B:C1709599
-	I:C1709599
based	I:C1709599
retrospective	O
study	I:C0035363
including	O
90	O
Swedish	O
children	O
(	O
median	O
13	O
years	O
)	O
with	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
was	O
performed	O
.	O

A	O
population	O
-	I:C1709599
based	I:C1709599
retrospective	B:C0035363
study	I:C0035363
including	O
90	O
Swedish	O
children	O
(	O
median	O
13	O
years	O
)	O
with	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
was	O
performed	O
.	O

A	O
population	O
-	I:C1709599
based	I:C1709599
retrospective	O
study	I:C0035363
including	O
90	O
Swedish	B:C1710263
children	O
(	O
median	O
13	O
years	O
)	O
with	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
was	O
performed	O
.	O

A	O
population	O
-	I:C1709599
based	I:C1709599
retrospective	O
study	I:C0035363
including	O
90	O
Swedish	O
children	O
(	O
median	O
13	O
years	O
)	O
with	O
inflammatory	B:C0021390
bowel	I:C0021390
disease	I:C0021390
was	O
performed	O
.	O

Patient	B:C0025102
records	I:C0025102
covered	O
in	O
median	O
25	O
months	O
.	O

Iron	B:C0240066
deficiency	I:C0240066
was	O
present	O
in	O
70/77	O
children	O
(	O
91	O
%	O
)	O
in	O
which	O
iron	O
status	I:C0337439
could	O
be	O
assessed	O
.	O

Iron	O
deficiency	I:C0240066
was	O
present	O
in	O
70/77	O
children	O
(	O
91	O
%	O
)	O
in	O
which	O
iron	B:C0337439
status	I:C0337439
could	O
be	O
assessed	O
.	O

In	O
clinical	O
and	O
biochemical	O
remission	B:C0544452
,	O
iron	O
deficiency	I:C0240066
was	O
found	O
in	O
57/67	O
(	O
85	O
%	O
)	O
of	O
children	O
,	O
and	O
23	O
(	O
34	O
%	O
)	O
of	O
them	O
had	O
iron	O
deficiency	I:C0162316
anemia	I:C0162316
.	O

In	O
clinical	O
and	O
biochemical	O
remission	O
,	O
iron	B:C0240066
deficiency	I:C0240066
was	O
found	O
in	O
57/67	O
(	O
85	O
%	O
)	O
of	O
children	O
,	O
and	O
23	O
(	O
34	O
%	O
)	O
of	O
them	O
had	O
iron	O
deficiency	I:C0162316
anemia	I:C0162316
.	O

In	O
clinical	O
and	O
biochemical	O
remission	O
,	O
iron	O
deficiency	I:C0240066
was	O
found	O
in	O
57/67	O
(	O
85	O
%	O
)	O
of	O
children	O
,	O
and	O
23	O
(	O
34	O
%	O
)	O
of	O
them	O
had	O
iron	B:C0162316
deficiency	I:C0162316
anemia	I:C0162316
.	O

Thirty	O
-	O
six	O
iron	B:C0240066
-	I:C0240066
deficient	I:C0240066
children	O
were	O
prescribed	O
oral	O
iron	O
supplementation	I:C3537005
and	O
32	O
(	O
89	O
%	O
)	O
improved	O
hemoglobin	O
levels	I:C0019029
over	O
6	O
months	O
.	O

Thirty	O
-	O
six	O
iron	O
-	I:C0240066
deficient	I:C0240066
children	O
were	O
prescribed	O
oral	B:C0001563
iron	O
supplementation	I:C3537005
and	O
32	O
(	O
89	O
%	O
)	O
improved	O
hemoglobin	O
levels	I:C0019029
over	O
6	O
months	O
.	O

Thirty	O
-	O
six	O
iron	O
-	I:C0240066
deficient	I:C0240066
children	O
were	O
prescribed	O
oral	O
iron	B:C3537005
supplementation	I:C3537005
and	O
32	O
(	O
89	O
%	O
)	O
improved	O
hemoglobin	O
levels	I:C0019029
over	O
6	O
months	O
.	O

Thirty	O
-	O
six	O
iron	O
-	I:C0240066
deficient	I:C0240066
children	O
were	O
prescribed	O
oral	O
iron	O
supplementation	I:C3537005
and	O
32	O
(	O
89	O
%	O
)	O
improved	O
hemoglobin	B:C0019029
levels	I:C0019029
over	O
6	O
months	O
.	O

In	O
conclusion	O
,	O
iron	B:C0240066
deficiency	I:C0240066
is	O
common	O
during	O
clinical	O
remission	O
in	O
children	O
with	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
,	O
even	O
in	O
cohorts	O
with	O
low	O
prevalence	O
of	O
anemia	O
.	O

In	O
conclusion	O
,	O
iron	O
deficiency	I:C0240066
is	O
common	O
during	O
clinical	O
remission	B:C0544452
in	O
children	O
with	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
,	O
even	O
in	O
cohorts	O
with	O
low	O
prevalence	O
of	O
anemia	O
.	O

In	O
conclusion	O
,	O
iron	O
deficiency	I:C0240066
is	O
common	O
during	O
clinical	O
remission	O
in	O
children	O
with	O
inflammatory	B:C0021390
bowel	I:C0021390
disease	I:C0021390
,	O
even	O
in	O
cohorts	O
with	O
low	O
prevalence	O
of	O
anemia	O
.	O

In	O
conclusion	O
,	O
iron	O
deficiency	I:C0240066
is	O
common	O
during	O
clinical	O
remission	O
in	O
children	O
with	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
,	O
even	O
in	O
cohorts	B:C0599755
with	O
low	O
prevalence	O
of	O
anemia	O
.	O

In	O
conclusion	O
,	O
iron	O
deficiency	I:C0240066
is	O
common	O
during	O
clinical	O
remission	O
in	O
children	O
with	O
inflammatory	O
bowel	I:C0021390
disease	I:C0021390
,	O
even	O
in	O
cohorts	O
with	O
low	O
prevalence	O
of	O
anemia	B:C0002871
.	O

Therefore	O
,	O
regular	O
biochemical	B:C1278201
screening	I:C1278201
for	O
iron	O
deficiency	I:C0240066
is	O
warranted	O
during	O
all	O
stages	O
of	O
disease	O
,	O
irrespective	O
of	O
symptoms	O
and	O
inflammatory	O
blood	O
markers	O
.	O

Therefore	O
,	O
regular	O
biochemical	O
screening	I:C1278201
for	O
iron	B:C0240066
deficiency	I:C0240066
is	O
warranted	O
during	O
all	O
stages	O
of	O
disease	O
,	O
irrespective	O
of	O
symptoms	O
and	O
inflammatory	O
blood	O
markers	O
.	O

Therefore	O
,	O
regular	O
biochemical	O
screening	I:C1278201
for	O
iron	O
deficiency	I:C0240066
is	O
warranted	O
during	O
all	O
stages	O
of	O
disease	B:C0012634
,	O
irrespective	O
of	O
symptoms	O
and	O
inflammatory	O
blood	O
markers	O
.	O

Therefore	O
,	O
regular	O
biochemical	O
screening	I:C1278201
for	O
iron	O
deficiency	I:C0240066
is	O
warranted	O
during	O
all	O
stages	O
of	O
disease	O
,	O
irrespective	O
of	O
symptoms	B:C1457887
and	O
inflammatory	O
blood	O
markers	O
.	O

Therefore	O
,	O
regular	O
biochemical	O
screening	I:C1278201
for	O
iron	O
deficiency	I:C0240066
is	O
warranted	O
during	O
all	O
stages	O
of	O
disease	O
,	O
irrespective	O
of	O
symptoms	O
and	O
inflammatory	O
blood	B:C0005767
markers	O
.	O

Therefore	O
,	O
regular	O
biochemical	O
screening	I:C1278201
for	O
iron	O
deficiency	I:C0240066
is	O
warranted	O
during	O
all	O
stages	O
of	O
disease	O
,	O
irrespective	O
of	O
symptoms	O
and	O
inflammatory	O
blood	O
markers	B:C0005516
.	O

